首页> The Journal of urology> Heterogeneity in Genomic Risk Assessment from Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of Magnetic Resonance Imaging Targeted Biopsy.

Heterogeneity in Genomic Risk Assessment from Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of Magnetic Resonance Imaging Targeted Biopsy.

导出 OA

翻译打印收藏纠错

第一作者： Sanoj,Punnen

第一单位： Department of Urology, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, Florida.

作者： Sanoj,Punnen ^[1] ; Radka,Stoyanova ^[2] ; Deukwoo,Kwon ^[3] ; Isildinha M,Reis ^[3] ; Nachiketh,Soodana-Prakash ^[1] ; Chad R,Ritch ^[1] ; Bruno,Nahar ^[1] ; Mark L,Gonzalgo ^[1] ; Bruce,Kava ^[1] ; Yang,Liu ^[4] ; Himanshu,Arora ^[1] ; Sandra M,Gaston ^[2] ; Rosa P,Castillo Acosta ^[5] ; Alan Dal,Pra ^[2] ; Matthew,Abramowitz ^[2] ; Oleksandr N,Kryvenko ^[6] ; Elai,Davicioni ^[4] ; Alan,Pollack ^[2] ; Dipen J,Parekh ^[1]

作者单位： Department of Urology, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, Florida. ^[1] Department of Radiation Oncology, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, Florida. ^[2] Biostatistics and Bioinformatics Shared Resource and Department of Public Health Sciences, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida. ^[3] Research and Development, Decipher Biosciences, San Diego, California. ^[4] Department of Radiology, University of Miami Miller School of Medicine, Miami, Florida. ^[5] Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, Florida. ^[6]

关键词 biomarkers genomics magnetic resonance imaging prostatic neoplasms